EEF1A1P26

Across TCGA pan-cancer cohorts, EEF1A1P26 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of EEF1A1P26’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where EEF1A1P26 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EEF1A1P26 is over-expressed in tumor, although a few such as LUSC and KICH show the opposite, repressed pattern.

LIHC, UCEC, and LUSC are the cancer types where EEF1A1P26 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EEF1A1P26 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.022	<.001	6	view →
UCEC	All	IV	+0.150	.017	2	view →
LUSC	Female	III,IV	−0.075	.004	1	view →
KICH	Female	All	−0.041	.029	1	view →
KIRP	All	All	−0.030	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

EEF1A1P26–LIHC

Open the LIHC breakdown →